| Product NDC: | 17433-9877 |
| Proprietary Name: | ENEMEEZ Plus |
| Non Proprietary Name: | DOCUSATE SODIUM and BENZOCAINE |
| Active Ingredient(s): | 20; 283 mg/5mL; mg/5mL & nbsp; DOCUSATE SODIUM and BENZOCAINE |
| Administration Route(s): | RECTAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17433-9877 |
| Labeler Name: | Enemeez Inc. DBA Summit Pharmaceuticals |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part334 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20120615 |
| Package NDC: | 17433-9877-3 |
| Package Description: | 30 TUBE in 1 BOTTLE (17433-9877-3) > 5 mL in 1 TUBE (17433-9877-0) |
| NDC Code | 17433-9877-3 |
| Proprietary Name | ENEMEEZ Plus |
| Package Description | 30 TUBE in 1 BOTTLE (17433-9877-3) > 5 mL in 1 TUBE (17433-9877-0) |
| Product NDC | 17433-9877 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | DOCUSATE SODIUM and BENZOCAINE |
| Dosage Form Name | LIQUID |
| Route Name | RECTAL |
| Start Marketing Date | 20120615 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Enemeez Inc. DBA Summit Pharmaceuticals |
| Substance Name | BENZOCAINE; DOCUSATE SODIUM |
| Strength Number | 20; 283 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes |